在整体股市疲软的交易日中，达维塔保健股票展现出相对韧性。尽管股价下跌2.01%，收于140.53美元，其表现却优于主要同行。标普500指数同期下滑0.40%至6,243.76点，道琼斯工业平均指数则重挫0.98%至44,023.29点。
达维塔保健收盘价较1月31日触及的52周高点179.60美元低21.75%，突显市场波动中的回调压力。
与竞争对手相比，该股优势明显：联合健康集团股价大跌2.95%至291.71美元，Icon PLC下挫2.64%至145.58美元，探索诊断公司也下滑1.16%至166.42美元。
交易量方面，达维塔保健仅为672,925股，显著低于其50天平均量821,885股，表明市场交投相对清淡。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.